Declaration of Fourth Interim Dividend

The Company announces the payment of the fourth interim dividend in respect of the year ended 30 September 2024 of 4.2 pence per ordinary share (2023: 4.0 pence per ordinary share).

The dividend will be paid on 24 January 2025 to all shareholders on the register on 13 December 2024. The ex- dividend date is 12 December 2024.

The payment of the fourth interim dividend brings the total dividend for the financial year to 16.8 pence per ordinary share (2023: 16.0 pence per ordinary share). This is an overall increase of 5% on the Company's total dividend payment for the previous financial year and, based on the share price on 25 November 2024, represents a 3.1% dividend yield.

Dividend Reinvestment Plan ("DRIP")

The Company has in place a DRIP, provided by Equiniti Financial Services Limited, which allows shareholders to use their dividends to purchase further ordinary shares in the Company. The last election date to participate in the DRIP is 3 January 2025.

Further information on the DRIP including the Terms and Conditions and the associated costs can be found via the following link:

https://www.shareview.co.uk/4/Info/Portfolio/default/en/home/shareholders/Pages/Rei nvestDividends.aspx

Shareholders who have not previously applied to participate in the DRIP and who wish to do so in respect of the dividend payable on 24 January 2025, should ensure that a mandate form, or CREST instruction if appropriate, is submitted to the Company's registrars, Equiniti Limited, prior to the dividend election date of 3 January 2025. Applications can be made on-line, and a mandate form can be downloaded from the above website.

Further information can also be obtained by calling the registrars' shareholder helpline on 0371 384 2618 or by writing to Equiniti Limited, Aspect House, Spence Road, Lancing, West Sussex BN99 6DA.

For further information please contact:

Paul Evitt

GPMS Corporate Secretary Limited

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DIVBFBBTMTBTBII]]>